PRP vs. Amniotic Mesenchymal Stem Cells: Understanding the Difference in Hair Restoration
By Dr. Keith Kantor, PhD, ND, Trichologist
Clinical Director, Regen Therapeutics
Platelet-Rich Plasma, better known as PRP, has become a familiar term in regenerative
medicine and hair restoration. PRP is created by drawing a patient’s blood, spinning it in a
centrifuge, and concentrating the platelets into a smaller volume of plasma. Those platelets
contain growth factors that may help signal repair, improve circulation, and support the
scalp environment.
For many patients, PRP can be a useful option. It uses the patient’s own biology, is
minimally invasive, and has been widely discussed in aesthetic and orthopedic medicine.
But PRP has limits. It does not provide new stem cells. Its potency can vary from patient to
patient based on age, health, medications, inflammation, and platelet quality. In simple
terms, PRP may stimulate—but it does not replace or replenish.
That distinction matters in hair restoration. Hair follicles under stress often need more than
a signal. They may benefit from a stronger regenerative environment that supports repair,
cellular communication, and healthier follicle function.
This is where amniotic mesenchymal stem cell therapy has drawn growing interest. These
cells are derived from donated umbilical cord tissue processed under strict standards.
Because they originate from early-stage biologic tissue, they are often described as highly
active, youthful, and efficient in their signaling capacity.
Mesenchymal stem cells are known for their ability to communicate with surrounding
tissue through growth factors, cytokines, and extracellular vesicles such as exosomes.
Rather than acting as a simple booster, they may help calm inflammation, support tissue
remodeling, improve the follicle microenvironment, and encourage dormant follicles to
function more normally.
Another key advantage is consistency. Unlike PRP, which depends on the patient’s own
blood quality on the day of treatment, professionally prepared biologic products can offer a
more standardized regenerative profile.
Patients often ask which option is “better.” The honest answer depends on the individual.
Some people do well with PRP. Others may be better candidates for a more advanced
regenerative approach. In clinical practice, treatment plans should be based on the cause of
hair loss, scalp condition, age, goals, and timeline.
The larger point is that not all regenerative therapies are the same. PRP is one category.
Advanced stem cell–based biologics are another. As technology evolves, patients now have
options that go beyond older one-size-fits-all approaches.
Anyone considering treatment should work with an experienced medical professional who
can explain realistic expectations, timing, and the best strategy for their specific pattern of
hair loss.
By: Dr. Keith Kantor, PhD, ND, Trichologist
ReGen Therapeutics
6065 Roswell Rd.
Suite 580 Sandy Springs, GA 30328
404-907-4225